Alcon

Alcon

Signal active

Investment Firm

Overview

Alcon is a medical device manufacturing company that develops and manufactures innovative medicines and devices to serve the full life cycle of eye care needs. It specializes in the fields of ophthalmology pharmaceuticals and medical devices, eye care, and eye health.

The company was founded in 1945 and headquartered in Geneva, Switzerland.

Highlights

Founded

1945

Industry

Health Care

Employees

10001+

Investment

2

Lead Investment

2

Exits

1

Stages

N/A

Investor Type

N/A

Location

Vernier, Geneve, Switzerland, Europe

Contact Information

Social

Profile Resume

Alcon, established in 1945 and headquartered in Switzerland, Europe., specializes in investments across Biotechnology, Health Care, Medical, Biopharma, Financial Services, Venture Capital, Impact Investing, Hedge Funds, Software, Computer Vision. The organization boasts a portfolio of 2 investments, with an average round size of $120.0M and 1 successful exits. Their recent investments include Aurion Biotechnologies, Deerfield, Petrichor Healthcare Capital Management, SensoMotoric Instruments (SMI). The highest investment round they participated in was $6.2B. Among their most notable exits are Aurion Biotechnologies and Deerfield. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Gerald Cagle

Gerald Cagle

VP, R&D

imagePlace Tom Padrick

Tom Padrick

Director Research

imagePlace Gisele Maxwell

Gisele Maxwell

Principal Engineer II

imagePlace Onuscheck Michael

Onuscheck Michael

President, Global Business and Innovation

imagePlace Joseph Weatherbee

Joseph Weatherbee

Director, Senior Legal Counsel IP

imagePlace Tim Stonesifer

Tim Stonesifer

Chief Financial Officer

Investment portfolio

Alcon has made 2 investments. Their most recent investment was on Apr 12, 2022, when Aurion Biotechnologies raised $120.0M.

investments

2

Diversity investments

0

Lead investments

2

Number of exits

1

Investments

2

Annouced DateOrganization NameIndustryMoney Raised
Nov 20, 2012
SensoMotoric Instruments (SMI) SensoMotoric Instruments (SMI)
Softwarenull
Apr 12, 2022
Aurion Biotechnologies Aurion Biotechnologies
Biotechnology120.0M

Exits

1

Funding Timeline

Funding rounds

2

Investors

0

Funds

0

Funding Rounds

2

Alcon has raised 2 rounds. Their latest funding was raised on Apr 12, 2022 from a Venture Round - Aurion Biotechnologies round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Nov 20, 2012
Venture Round - SensoMotoric Instruments (SMI) Venture Round - SensoMotoric Instruments (SMI)
-0-
Apr 12, 2022
Venture Round - Aurion Biotechnologies Venture Round - Aurion Biotechnologies
-120.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries